FI102837B1 - T4-glykoproteiinin liukoista polypeptidiosaa koodaava nukleiinihappomolekyyli ja menetelmä polypeptidin tuottamiseksi - Google Patents

T4-glykoproteiinin liukoista polypeptidiosaa koodaava nukleiinihappomolekyyli ja menetelmä polypeptidin tuottamiseksi

Info

Publication number
FI102837B1
FI102837B1 FI895049A FI895049A FI102837B1 FI 102837 B1 FI102837 B1 FI 102837B1 FI 895049 A FI895049 A FI 895049A FI 895049 A FI895049 A FI 895049A FI 102837 B1 FI102837 B1 FI 102837B1
Authority
FI
Finland
Prior art keywords
polypeptide
glycoprotein
producing
nucleic acid
acid molecule
Prior art date
Application number
FI895049A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI102837B (fi
FI895049A0 (fi
Inventor
Paul J Maddon
Richard Axel
Raymond W Sweet
James Arthos
Original Assignee
Univ Columbia
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Smithkline Beckman Corp filed Critical Univ Columbia
Publication of FI895049A0 publication Critical patent/FI895049A0/fi
Application granted granted Critical
Publication of FI102837B1 publication Critical patent/FI102837B1/fi
Publication of FI102837B publication Critical patent/FI102837B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/821—Separation of nucleic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI895049A 1988-02-24 1989-10-24 T4-glykoproteiinin liukoista polypeptidiosaa koodaava nukleiinihappomo lekyyli ja menetelmä polypeptidin tuottamiseksi FI102837B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/160,348 US5110906A (en) 1986-08-21 1988-02-24 Derivatives of soluble T-4
US16034888 1988-02-24
PCT/US1989/000762 WO1989008143A1 (en) 1988-02-24 1989-02-24 Derivatives of soluble t-4
US8900762 1989-02-24

Publications (3)

Publication Number Publication Date
FI895049A0 FI895049A0 (fi) 1989-10-24
FI102837B1 true FI102837B1 (fi) 1999-02-26
FI102837B FI102837B (fi) 1999-02-26

Family

ID=22576514

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895049A FI102837B (fi) 1988-02-24 1989-10-24 T4-glykoproteiinin liukoista polypeptidiosaa koodaava nukleiinihappomo lekyyli ja menetelmä polypeptidin tuottamiseksi

Country Status (15)

Country Link
US (2) US5110906A (pt)
EP (1) EP0330227A3 (pt)
JP (1) JPH02503269A (pt)
KR (1) KR900700592A (pt)
AU (1) AU628072B2 (pt)
DE (1) DE330227T1 (pt)
DK (1) DK175816B1 (pt)
ES (1) ES2031805T1 (pt)
FI (1) FI102837B (pt)
GR (1) GR900300099T1 (pt)
HU (1) HU213019B (pt)
NZ (1) NZ228127A (pt)
PT (1) PT89838B (pt)
WO (1) WO1989008143A1 (pt)
ZA (1) ZA891456B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0280710B1 (en) 1986-08-21 1996-03-20 The Trustees Of Columbia University In The City Of New York Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
US5958678A (en) * 1986-08-21 1999-09-28 The Trustees Of Columbia University In The City Of New York DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS
US6673896B1 (en) * 1986-08-21 2004-01-06 The Trustees Of Columbia University In The City Of New York Derivatives of soluble T-4
US6710169B2 (en) 1987-10-02 2004-03-23 Genentech, Inc. Adheson variants
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
EP0432693A1 (en) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Liposomes cytotoxic to virus-infected cells
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
AU7976791A (en) * 1990-05-25 1991-12-31 Biogen, Inc. Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
AU9028791A (en) * 1990-10-05 1992-04-28 President And Fellows Of Harvard College Detection and isolation of ligands
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
US6274134B1 (en) 1992-01-29 2001-08-14 National Institutes Of Health Human cell adhesion protein AAMP-1 and uses thereof
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
US6503703B1 (en) * 1995-05-19 2003-01-07 Mount Sinai School Of Medicine Of New York University Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
DE69819150T3 (de) 1997-06-06 2007-12-20 Dynavax Technologies Corp., San Diego Immunstimulierende oligonucleotide, zusammensetzungen davon, und verfahren zur verwendung davon
US6797462B1 (en) 1998-06-23 2004-09-28 Uab Research Foundation Cell-based assay for immunodeficiency virus infectivity and sensitivity
US6586207B2 (en) * 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7323174B1 (en) * 2000-06-12 2008-01-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Modulation of immune response and methods based thereon
US7175988B2 (en) * 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
EP1419236A4 (en) 2001-07-24 2005-08-03 Biogen Idec Inc METHODS OF TREATING OR PREVENTING SCLEROSIS BY USE OF CD2-BINDING AGENTS
DE60236953D1 (de) * 2001-10-25 2010-08-19 Us Gov Health & Human Serv Effiziente hemmung des eintritts von hiv-1-virus durch ein neues fusionsprotein mit cd4
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7662921B2 (en) 2004-05-07 2010-02-16 Astellas Us Llc Methods of treating viral disorders
WO2006098724A1 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of California Methods for treating hiv by inhibiting cd4 down-modulation
US20080283557A1 (en) * 2007-05-17 2008-11-20 Julianne Desautels Spout for food stuff container
US8912047B2 (en) * 2011-05-18 2014-12-16 Infineon Technologies Ag Method for producing a metal layer on a substrate and device
KR20130049671A (ko) 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
AR090281A1 (es) 2012-03-08 2014-10-29 Hanmi Science Co Ltd Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144983A (en) * 1981-02-27 1982-09-07 Otsuka Pharmaceut Factory Inc Preparation of physiologically active substance
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
EP0280710B1 (en) * 1986-08-21 1996-03-20 The Trustees Of Columbia University In The City Of New York Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
US5109123A (en) * 1988-06-14 1992-04-28 Dana Farber Cancer Institute Alteration of ability of soluble CD4 fragments to bind HIV

Also Published As

Publication number Publication date
KR900700592A (ko) 1990-08-16
JPH02503269A (ja) 1990-10-11
FI102837B (fi) 1999-02-26
HU213019B (en) 1997-01-28
GR900300099T1 (en) 1991-09-27
DK528289A (da) 1989-12-22
AU4071889A (en) 1989-09-22
US5110906A (en) 1992-05-05
ZA891456B (en) 1990-01-31
HUT52814A (en) 1990-08-28
DE330227T1 (de) 1990-09-27
PT89838B (pt) 1994-02-28
US5422274A (en) 1995-06-06
EP0330227A3 (en) 1991-01-30
ES2031805T1 (es) 1993-01-01
DK175816B1 (da) 2005-03-07
FI895049A0 (fi) 1989-10-24
AU628072B2 (en) 1992-09-10
WO1989008143A1 (en) 1989-09-08
NZ228127A (en) 1991-11-26
PT89838A (pt) 1989-10-04
DK528289D0 (da) 1989-10-24
EP0330227A2 (en) 1989-08-30

Similar Documents

Publication Publication Date Title
FI102837B1 (fi) T4-glykoproteiinin liukoista polypeptidiosaa koodaava nukleiinihappomolekyyli ja menetelmä polypeptidin tuottamiseksi
ATA82487A (de) Verfahren zur rekombinanten herstellung eines proteins
PT88425A (pt) Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins
GB8901469D0 (en) Proteins and method for their production
FI874787A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
ATA112385A (de) Verfahren zur herstellung wenigstens zweilagiger gegenstände
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
DE3667489D1 (de) Verfahren zur herstellung eines proteins.
FI92052C (fi) Fenolin valmistusmenetelmä
ATA188886A (de) Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
GB2171091B (en) Method of producing concrete
EP0222412A3 (en) Method of producing peptides
ATA53886A (de) Verfahren zur herstellung von chlordioxid
HU893786D0 (en) Process for producing proteins and nucleinic acids
PT86275A (en) Method of producing a recombinant dna molecule
KR870700630A (ko) 지방족 포스폰산류의 제조방법
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
FI884550A0 (fi) DNA-rakenne ja menetelmä heterologisen proteiinin tuottamiseksi
ATA297985A (de) Verfahren zur herstellung von bis-indolverbindungen enthaltenden stabilen waesserigen arzneimittelpraeparaten
KR890700824A (ko) Ivb족 전이금속-알카리 금속-플로라이드 염의 생산방법 및 정제방법
KR880005263A (ko) 단백질의 신규제법
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ES550013A0 (es) Un metodo de produccion de un polipeptido funcional
DE3675252D1 (de) Verfahren zur herstellung von cordieritkeramiken.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE TRUSTEES OF COLUMBIA UNIVERSITY

Owner name: SMITHKLINE BECKMAN CORPORATION

MA Patent expired